H1 2026 Earnings
Financial report interval: 2025.12.30 - 2026.06.30
Overview: HANSOH PHARMA(03692) the Revenue is 9.584 B (+17.79%), Beat estimate;the EBIT is 4.278 B (+23.24%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
9.58B17.79%
9.27B13.89%
+0.32B3.90%
EBITExceed expectations
4.28B23.24%
3.45B0.70%
+0.83B23.94%
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf